Side effects of tesamorelin Like many injectable treatments, tesamorelin can cause injection site reactions (redness, swelling, mild discomfort) as well as joint and muscle pain
14.4 MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
Its also linked to metabolic disorders such as diabetes, and has been associated with depression and potentially cancer. Could help lower risk of some cancers A recent study looked at medical records for more than 10,000 people with early-stage cancer and found that those who took GLP-1s had a significantly lower risk of their cancer spreading than those who did not
We pride ourselves in having an all nursing staff of NPs that put safety as #1 priority.
Asian J Androl 16(2):262-265